INTERNATIONAL PATENT: PRECOGIFY PHARMACEUTICAL CHINA CO., LTD. FILES APPLICATION FOR "BIOMARKERS, SYSTEMS AND METHODS FOR PDAC PROGNOSIS AND PARP INHIBITOR RESPONSIVENESS"

GENEVA, Feb. 15 -- PRECOGIFY PHARMACEUTICAL CHINA CO., LTD. (A402, Zhongguancun Biomedicine Park, No. 5, Shangdi Kaituo RoadHaidian District, Beijing 100085) filed a patent application (PCT/CN2024/111060) for "BIOMARKERS, SYSTEMS, AND METHODS FOR PDAC PROGNOSIS AND PARP INHIBITOR RESPONSIVENESS" on Aug 09, 2024. With publication no. WO/2026/031174, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LIN, Kai (A402, Zhongguancun Biomedicine Park, No. 5, Shangdi Kaituo RoadHaidian District, Beijing 100085), GUO, Xingting (A402,...